Prevention Genetics Logo
Test Code 4673
New York approved

Multiple Endocrine Neoplasia Type 2A (MEN2A), Type 2B (MEN2B), and Familial Medullary Thyroid Carcinoma (FMTC) via the RET Gene

RET

2 - 3 weeks (7 - 16 days STAT)

Who is this test for?
  • Individuals with relevant features who have a clinical or suspected diagnosis of Multiple Endocrine Neoplasia Type 2 (MEN2)
  • Individuals with early-onset medullary thyroid carcinoma diagnosed before age 35
  • Individuals with relevant features who have a clinical or suspected diagnosis of Hirschsprung Disease (HSCR)
Method
NGS with CNV (PGselect Platform)
Specimen(s)

Blood, Buccal, Saliva, Tissue

Order Options

Test type
OTHER OPTIONS
for pricing.

Explore related tests

Questions? We can help.

Getting support has never been easier. Connect with our team for assistance with anything from test selection to interpreting results. Use the live chat button or visit our Contact us page.